Neuraminidase 1 is a driver of experimental cardiac hypertrophy

Volume: 42, Issue: 36, Pages: 3770 - 3782
Published: Jun 28, 2021
Abstract
Despite considerable therapeutic advances, there is still a dearth of evidence on the molecular determinants of cardiac hypertrophy that culminate in heart failure. Neuraminidases are a family of enzymes that catalyze the cleavage of terminal sialic acids from glycoproteins or glycolipids. This study sought to characterize the role of neuraminidases in pathological cardiac hypertrophy and identify pharmacological inhibitors targeting mammalian...
Paper Details
Title
Neuraminidase 1 is a driver of experimental cardiac hypertrophy
Published Date
Jun 28, 2021
Volume
42
Issue
36
Pages
3770 - 3782
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.